Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

SPB Exchange from February 1 will start trading on weekends

1/28/25 SPBE

Samolot will repurchase the bonds for 84-92% of the par value

1/28/25 SMLT

Henderson's revenue in 2024 is up 24.2%

1/28/25 HNFG

Digital Habits Group started collecting applications for Pre-IPO participation

1/28/25 OTCI

On MOEX Start another Pre-IPO has been launched

1/28/25 MOEX

Lambumiz reported growth in production volumes

1/28/25 LMBZ

Whoosh's audience in 2024 has grown by 35%

1/28/25 WUSH

Promsvyazbank may buy M.Video-Eldorado

1/28/25 MVID

Cian applied for delisting of receipts from Moscow Exchange

1/27/25 CIAN

Nornickel reported lower production figures

1/27/25 GMKN